Two Sigma Advisers’s Concentrix CNXC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-16,600
Closed -$690K 468
2025
Q4
$690K Buy
+16,600
New +$674K ﹤0.01% 1662
2025
Q2
Sell
-111,800
Closed -$6.22M 2352
2025
Q1
$6.22M Buy
111,800
+41,100
+58% +$1.97M 0.01% 690
2024
Q4
$3.06M Buy
70,700
+47,200
+201% +$2.1M 0.01% 922
2024
Q3
$1.2M Buy
+23,500
New +$1.57M ﹤0.01% 1327
2021
Q1
Sell
-2,400
Closed -$237K 2587
2020
Q4
$237K Buy
+2,400
New +$240K ﹤0.01% 2109

Other funds holding CNXC

Two Sigma Advisers's CNXC Position: Q1 2026 in Review

Two Sigma Advisers sold out of Concentrix (CNXC) in Q1 2026, closing a stake of 16,600 shares — an estimated $690K sold.

Two Sigma Advisers first reported a position in CNXC in Q4 2020 and held it in 5 quarters. The position peaked at $6.22M in Q1 2025. 304 funds tracked by Wall St. Rank hold CNXC as of Q1 2026.

  • Two Sigma Advisers reported no remaining Concentrix position as of Q1 2026 after selling out during the quarter.
  • Two Sigma Advisers sold 16,600 Concentrix shares in Q1 2026, an estimated $690K.
  • Two Sigma Advisers first reported a position in Concentrix in Q4 2020 and held it in 5 quarters.
  • Two Sigma Advisers's Concentrix position peaked at $6.22M in Q1 2025.
  • 304 funds tracked by Wall St. Rank held Concentrix as of Q1 2026.

Based on Two Sigma Advisers's 13F filing for Q1 2026.